We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK’s healthcare cost watchdog has issued a final guidance that will reimburse seven biologicals as options for treating severe rheumatoid arthritis in patients who have not responded to conventional treatments. Read More
Tuesday’s House Oversight and Government Reform Committee hearing on drug pricing has been pushed back to Feb. 4 after a weekend blizzard buried the Washington, D.C. region in snow. Read More
Lawmakers are threatening the pharmaceutical industry’s reigning bad boy Martin Shkreli with a contempt citation if he fails to show up for next week’s hearing on drug prices. Read More
With congressional efforts to pressure Gilead Sciences into lowering the price of two hepatitis C drugs floundering, members of the Senate Finance Committee are taking their concerns directly to the public. Read More
Six compounders are suing Express Scripts, accusing the nation’s largest PBM of participating in a massive conspiracy to put independent compounders out of business. Read More
GlaxoSmithKline said it plans to improve its data protection policies in the wake of a federal indictment in Philadelphia this week accusing two former researchers of plotting to steal trade secrets for possible sale to China. Read More